Pietro Enea Lazzerini Selected Research

Pietro Enea Lazzerini Research Topics

Disease

16	Inflammation (Inflammations) 01/2022 - 02/2005
10	COVID-19 11/2022 - 01/2020
9	Long QT Syndrome 09/2021 - 01/2016
7	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2008
6	Torsades de Pointes (Torsade de Pointes) 01/2021 - 04/2016
6	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2007
6	Hyperhomocysteinemia 05/2016 - 07/2003
5	Ischemic Stroke 01/2021 - 05/2016
5	Arthritis (Polyarthritis) 01/2019 - 10/2008
4	Infections 01/2022 - 11/2017
4	Atrioventricular Block 01/2022 - 02/2015
4	Heart Arrest (Cardiac Arrest) 01/2021 - 09/2017
4	Rheumatoid Arthritis 11/2017 - 08/2008
3	Channelopathies 01/2021 - 09/2017
3	Atrial Remodeling 01/2020 - 01/2017
3	Fibrosis (Cirrhosis) 12/2015 - 03/2012
3	Systemic Scleroderma (Systemic Sclerosis) 04/2015 - 03/2012
3	Connective Tissue Diseases (Connective Tissue Disease) 03/2012 - 04/2004
3	Congenital heart block 10/2011 - 01/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2011 - 11/2004
2	Stroke (Strokes) 01/2022 - 05/2016
2	Heart Diseases (Heart Disease) 09/2021 - 01/2018
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019 - 10/2013
2	Tachycardia (Tachyarrhythmias) 09/2017 - 10/2008
2	Rheumatic Diseases (Rheumatism) 04/2011 - 08/2008
2	Heart Failure 02/2005 - 02/2003
2	Renal Insufficiency (Renal Failure) 11/2004 - 07/2003
1	Diarrhea 01/2022
1	Atrial Fibrillation 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Cortical Blindness (Anton Syndrome) 01/2022
1	Agnosia (Visual Agnosia) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022
1	Infarction (Infarctions) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Autoimmune Hepatitis 10/2021
1	Hypothyroidism 09/2021
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Sick Sinus Syndrome 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Ventricular Tachycardia 01/2018
1	Necrosis 11/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2017
1	Left Ventricular Dysfunction 06/2017

Drug/Important Bio-Agent (IBA)

11	Interleukin-6 (Interleukin 6)IBA 11/2022 - 08/2008
10	CytokinesIBA 01/2022 - 02/2003
10	AntibodiesIBA 01/2021 - 04/2004
7	C-Reactive ProteinIBA 01/2022 - 06/2013
7	AutoantibodiesIBA 01/2021 - 05/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 03/2007
5	HomocysteineIBA 05/2016 - 07/2003
4	Potassium Channels (Potassium Channel)IBA 01/2021 - 01/2016
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2022
3	Pharmaceutical PreparationsIBA 09/2021 - 10/2008
3	Ion Channels (Ion Channel)IBA 01/2021 - 09/2017
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2017 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 01/2010 - 07/2003
2	Anti-Arrhythmia AgentsIBA 01/2022 - 03/2015
2	Anti-Idiotypic AntibodiesIBA 01/2021 - 04/2016
2	Monoclonal AntibodiesIBA 01/2017 - 01/2016
2	Biological ProductsIBA 01/2017 - 12/2015
2	CannabinoidsIBA 09/2012 - 03/2012
2	Cysteine (L-Cysteine)FDA Link 11/2004 - 07/2003
2	cysteinylglycine (Cys-Gly)IBA 11/2004 - 07/2003
2	DisulfidesIBA 11/2004 - 07/2003
2	Sulfhydryl Compounds (Thiols)IBA 11/2004 - 07/2003
2	Glutathione (Reduced Glutathione)IBA 11/2004 - 07/2003
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	Ritonavir (Norvir)FDA Link 01/2022
1	Drug CombinationsIBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Lopinavir FDA Link 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	P-2 (P 2)IBA 01/2022
1	Connexin 43 (Connexin43)IBA 11/2021
1	VaccinesIBA 10/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Ether (Diethyl Ether)IBA 01/2021
1	AntigensIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	AndrogensIBA 01/2020
1	Calcium Channels (Calcium Channel)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ConnexinsIBA 01/2019
1	CalciumIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 11/2017
1	Lansoprazole (Prevacid)FDA LinkGeneric 11/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2015
4	Heart Transplantation (Grafting, Heart) 05/2016 - 02/2003
2	Thrombectomy 01/2022 - 09/2017
2	Mechanical Thrombolysis 01/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2022
1	Personal Protective Equipment 01/2022
1	Off-Label Use 01/2022
1	Thrombolytic Therapy 09/2017